Skip to content
Pharma Observatory a Scientist.com platform

Organization (Other)

Medtronic Cardiovascular

ClinicalTrials.gov lists Medtronic Cardiovascular as lead sponsor of 70 trials.

Other
Email me this page as a PDF

Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

8 0 2001 2026

Trials started per year with this organization as sponsor or collaborator, 1990 onward. The series also counts trials where the organization is a collaborator; the lead-sponsor trial count does not.

2026 is partial: 2 registered with a 2026 start date. The dashed outline is the pace from the 2 registered with a start date through September, planned starts included, not adjusted; not a forecast. No forecast is made for this organization: it averages 1.6 trial starts a year over the five years to September, under the 5 a year the method needs.

This page covers Medtronic Cardiovascular: 70 lead-sponsored trials and 0 legal-entity registrations.

Get the Medtronic Cardiovascular report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Disease areas (26)

Shown in this order: most trials first.

Disease areas
Disease area Trials
Aortic Aneurysm 27
Aortic Valve Stenosis 19
Aortic Aneurysm, Abdominal 17
Aortic Aneurysm, Thoracic 11
Mitral Valve Insufficiency 4

Trials by start year as sponsor or collaborator (23)

Shown in this order: most recent first. 2026 is partial: trials registered with a 2026 start date so far, not a full year.

Show the table of trials by start year as sponsor or collaborator
Trials by start year as sponsor or collaborator
Year Trials started
2026 (partial year) 2
2025 2
2023 2
2022 1
2021 4
2020 3
2019 1
2018 3
2017 2
2016 7

Recruitment duration, a model prediction: 4 trials still running at the 2026-10-09 snapshot, fewer than the 5 needed for a median. Source: ClinicalTrials.gov / AACT (CTTI), public domain.

Sponsor delivery record (1)

Enrollment hit target: the share of this sponsor's lead-sponsored trials whose actual enrollment reached the planned enrollment. On time: the share whose actual primary completion date was no later than the planned date. Each share counts only trials where we observed an estimated figure before the actual one, and n is that number of trials. Below 5 trials the count is shown as a fraction, not a percentage.

Sponsor delivery record
Enrollment Timeline
56% hit target (n=18) 52% on time (n=21)

Journals published in (31)

Shown in this order: most published in first.

Journals published in
Journal Publications
Journal of the American College of Cardiology 24
Journal of vascular surgery 20
JACC. Cardiovascular interventions 16
Circulation. Cardiovascular interventions 14
EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology 10

Latest dated events (72)

Shown in this order: newest first.

Latest dated events
Date Event Source
2026-09-11 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))
2026-08-26 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))
2025-07-30 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))
2025-02-06 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))
2023-02-07 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))

Biomarker capability evidence (25)

Shown in this order: tier desc, then gene symbol.

Biomarker capability evidence
Gene Role Evidence
BSG Trial sponsor Named in trial inclusion criteria
EGR3 Trial sponsor Named in trial inclusion criteria
MLIP Trial sponsor Named in trial inclusion criteria
MLIP Trial sponsor Named in trial inclusion criteria
MLIP Trial sponsor Named in trial inclusion criteria

Not on this page

Checked, with nothing recorded for this organization: companies grouped under this page, related companies not grouped here, active development programs, approved assets, us granted patents, sec-reported annual financials, financing and grant events, fda warning letters, fda untitled letters, fda inspection record, fda recalls, fda import refusals, manufacturing and distribution sites, climate targets, as filed, workforce and board diversity, as filed, organization relationships, clia clinical laboratory certificates, and biomarkers this organization publishes on.